Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Filings indexed 814 across all filing types
Latest filing 2023-03-27 Proxy Solicitation & In…
Country IT Italy
Listing XMIL DIA

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
DiaSorin S.p.A. - Assemblea Ordinaria degli Azionisti del 28 aprile 2023 - Modulo di delega ex art. 135-undecies TUF
Proxy Solicitation & Information Statement Classification · 99% confidence The document is titled "MODULO DI CONFERIMENTO DELLA DELEGA AL RAPPRESENTANTE DESIGNATO AI SENSI DELL'ART. 135-UNDECIES DEL D. LGS. 58/1998 ('TUF')". This translates to a 'Proxy Form for Conferring Delegation to the Designated Representative' under Italian law (TUF). It explicitly deals with shareholders delegating their voting rights to a designated representative (Monte Titoli S.p.A.) for an upcoming Ordinary Shareholders' Meeting (Assemblea Ordinaria) scheduled for April 28, 2023. This document's primary function is to solicit and record shareholder voting instructions for a general meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it relates to the AGM, the document itself is the mechanism for proxy voting, not the AGM presentation (AGM-R) or the voting results (DVA).
2023-03-27 Italian
Shareholders' Meeting April 28, 2023 - Proxy forms ex art. 135-novies TUF
Proxy Solicitation & Information Statement Classification · 99% confidence The document is explicitly titled 'PROXY FORM TO THE APPOINTED REPRESENTATIVE' and contains detailed instructions for shareholders on how to delegate their voting rights for an upcoming 'Ordinary General Meeting of DIASORIN S.p.A.' scheduled for April 28, 2023. It includes sections for voting instructions on resolutions (like approval of Financial Statements and dividend distribution). This material is designed to solicit shareholder votes and provide necessary information ahead of a general meeting, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). It is not the AGM presentation itself (AGM-R), nor is it the full Annual Report (10-K) or an Earnings Release (ER).
2023-03-27 English
Assemblea Ordinaria degli Azionisti del 28 aprile 2023 - Modulo di delega ex art. 135-novies TUF
Proxy Solicitation & Information Statement Classification · 98% confidence The document is a formal Italian document titled "MODULO DI CONFERIMENTO DELLA DELEGA/SUBDELEGA AL RAPPRESENTANTE DESIGNATO AI SENSI DELL'ART. 135-NOVIES DEL D. LGS. 58/1998 ('TUF')". This translates to a 'Form for Conferring Proxy/Sub-proxy to the Designated Representative' under Italian securities law (TUF). It explicitly deals with granting voting rights instructions to a designated proxy (Monte Titoli S.p.A.) for an upcoming shareholder meeting of DIASORIN S.p.A. on April 28, 2023. This type of document, which solicits shareholder instructions for voting at a general meeting, falls under the category of Proxy Solicitation & Information Statement (PSI). It is not the AGM presentation itself (AGM-R), nor is it the full annual report (10-K) or an earnings release (ER).
2023-03-27 Italian
DiaSorin S.p.A. - Ordinary Shareholders' Meeting April 28, 2023 - Notice
AGM Information Classification · 100% confidence The document text explicitly states in the 'Oggetto' (Subject) field: 'DiaSorin S.p.A. - Ordinary Shareholders' Meeting April 28, 2023 - Notice'. The body of the text details the convening of the 'Ordinary Shareholders' Meeting' on April 28, 2023, and outlines the agenda items, which include approval of financial statements, remuneration policy, and stock options plans. This content is characteristic of a formal notice for an Annual General Meeting (AGM). Although it mentions financial statements (which might suggest 10-K or IR), the primary purpose and title clearly identify it as the notice for the shareholders' meeting itself. Therefore, the most appropriate classification is AGM-R (AGM Information).
2023-03-27 Italian
DiaSorin S.p.A. - Assemblea Ordinaria degli Azionisti 28 aprile 2023 – Avviso di convocazione
AGM Information Classification · 99% confidence The document is an official notice titled 'DiaSorin S.p.A. - Assemblea Ordinaria degli Azionisti 28 aprile 2023 – Avviso di convocazione' (Notice of Convocation for the Ordinary Shareholders' Meeting). It details the date, time, location (with provisions for remote participation due to COVID-19 measures), and the specific 'Ordine del Giorno' (Agenda). The agenda items include the approval of the 2022 Financial Statements, dividend distribution, remuneration policy, and authorization for stock option plans and share buybacks. This content is characteristic of materials related to an Annual General Meeting (AGM) or the formal notice preceding it. Since the document is the official notice/convocation for the AGM, the most appropriate classification is AGM-R (AGM Information), as it directly pertains to the meeting logistics and agenda.
2023-03-27 Italian
DiaSorin S.p.A. - Update 2023 Annual Calendar of Corporate Events
Report Publication Announcement Classification · 99% confidence The document is an official notice from DiaSorin S.p.A. titled 'DiaSorin S.p.A. – Update 2023 Annual Calendar of Corporate Events'. It details scheduled dates for key corporate activities, including Board of Directors meetings for approving quarterly results, the date for the Annual General Meeting (AGM) to approve the 2022 Financial Statements, and a notification regarding the potential dividend payment month. Since the document's primary purpose is to announce the schedule for future corporate events, including the AGM and financial report approvals, it functions as a general corporate update or announcement regarding future reporting/meetings. Given the specific mention of the 'Annual General Meeting' date and purpose, and the fact that it is an update to a calendar, it strongly relates to AGM planning. However, it is not the AGM presentation itself (AGM-R) or the proxy materials (PSI). It is an announcement about corporate events. The closest fit among the provided codes for a general update on corporate schedules, including the AGM date, is often captured under Regulatory Filings (RNS) if no other specific code fits perfectly, or potentially a general Investor Relations document. Since it explicitly schedules the AGM, and the AGM is a major corporate event, I will check if it fits better elsewhere. It is not an Earnings Release (ER), nor a full report (10-K, IR). It is an announcement of dates. Because it announces the date of the AGM and other key financial report approvals, and it is a formal regulatory communication ('Informazione Regolamentata'), it is best classified as a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if it were announcing the publication of a report, which it is not doing directly, but rather announcing the *schedule* for approvals. Given the content is a calendar update, RNS is the most appropriate fallback for this type of scheduling announcement that doesn't fit the specific report/release codes.
2023-03-27 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.